Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis: A pilot study

JAMA

Volumn 282, Issue 17, 1999, Pages 1659-1664

  Cortez Pinto, Helena ^a   Chatham, John ^a   Chacko, V P ^a   Arnold, Cheryl ^a   Rashid, Asif ^a   Diehl, Anna Mae ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ALBUMIN; AMINOTRANSFERASE; BILIRUBIN; CHOLESTEROL; FRUCTOSE; GLUCOSE; TRIACYLGLYCEROL;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FATTY LIVER; FEMALE; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HUMAN; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER MITOCHONDRION; MALE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OBESITY; PILOT STUDY; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0033520771     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.282.17.1659     Document Type: Article

References (28)

1. Nomura H, Kashiwagi S, Hayashi J, Kajiyama W, Tani S, Goto M. Prevalence of fatty liver in a general population of Okinawa, Japan. Jpn J Med. 1988;27:142-149.
2. Lonardo A, Bellini M, Tartoni P, Tondelli E. The bright liver syndrome: prevalence and determinants of a "bright" liver echo pattern. Ital J Gastroenterol Hepatol. 1997;29:351-356.
3. el-Hassan AY, Ibrahim EM, al-Mulhim FA, Nabhan AA, Chammas MY. Fatty infiltration of the liver: analysis of prevalence, radiological and clinical features and influence on patient management. Br J Radiol. 1992;65:774-778.
4. Bellentani S, Tiribelli C, Saccoccio G, et al. Prevalence of chronic liver disease in the general population of northern Italy: the Dyonisos Study. Hepatology. 1994;20:1442-1449.
5. Thaler H. Relation of steatosis to cirrhosis. Clin Gastroenterol. 1975;4:273-280.
6. Ludwig J, Viggiano RT, McGil DB. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc. 1980;55:342-348.
7. Okolo PI, Diehl AM. Nonalcoholic steatohepatitis and focal fatty liver. In: Feldman M, Scharschmidt BF, Sleisenger MH, eds. Sleisenger and Fordtran's Gastrointestinal and Liver Disease. 6th ed. Philadelphia, Pa: WB Saunders Co; 1998:1215-1220.
8. Sheth SG, Gordon FD, Chopar S. Nonalcoholic steatohepatitis. Ann Intern Med. 1997;126:137-145.
9. Lee RG. Nonalcoholic steatohepatitis: a study of 49 patients. Hum Pathol. 1989;20:594-599.
10. Powell EE, Cooksley GE, Hanson R, Searle J, Halliday RW, Powell LW. The natural history of nonalcoholic steatohepatitis: a follow-up study of 42 patients followed for up to 21 years. Hepatology. 1990;11:74-80.
11. Caldwell SH, Oelsner DH, Iezzoni JC, Hespenheide EE, Battle EH, Driscoll CJ. Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology. 1999;29:664-669.
12. Campfield LA, Smith FJ, Bum P. The OB protein (leptin) pathway: a link between adipose tissue mass and central neural networks. Horm Metab Res. 1996; 28:619-632.
13. Yang SQ, Lin HZ, Lane MD, Clemens M, Diehl AM. Obesity increases sensitivity to endotoxin liver injury: implications for pathogenesis of steatohepatitis. Proc Natl Acad Sci USA. 1997;94:2557-2562.
14. Chavin K, Yang SQ, Lin HZ, et al. Obesity induces expression of uncoupling protein-2 in hepatocytes and promotes liver ATP depletion. J Biol Chem. 1999;274:5692-5700.
15. Fleury C, Neverova M, Collins S, et al. Uncoupling protein-2: a novel gene linked to obesity and hyperinsulinemia. Nat Genet. 1997;15:269-272.
16. Boss O, Muzzin P, Giacobino JP. The uncoupling proteins: a review. Eur J Endocrinol. 1998;139:1-9.
17. Terrier F, Vock P, Cotting J, Ladebeck R, Reichen J, Hentschel D. Effect of intravenous fructose on the P-31 spectrum of the liver: dose response in healthy volunteers. Radiology. 1989;17:557-563.
18. Oberhaensli RD, Galloway GJ, Taylor DJ, Phil D, Bore J, Radda G. Assessment of human liver metabolism by phosphorus-31 magnetic resonance spectroscopy. Br J Radiol. 1986;59:695-699.
19. Lee RG. Nonalcoholic steatohepatitis: tightening the morphological screws on a hepatic rambler. Hepatology. 1995;21:1742-1744.
20. Fram J, Bruhn H, Gyngell ML, Merboldt KD, Hanicke W, Sauter R. Localized high-resolution proton NMR spectroscopy using stimulated echoes: initial applications to human brain in vivo. Magn Reson Med. 1989;9:79-93.
21. Weiss RG, Bottomley PA, Hardy CJ, Gerstenblith G. Regional myocardial metabolism of high-energy phosphates during isometric exercises in patients with coronary artery disease. N Engl J Med. 1990;323:1593-1600.
22. Bacon B, Faravash MJ, Janney CG, et al. Nonalcoholic steatohepatitis: an expanded clinical entity. Gastroenterology. 1994;107:1103-1106.
23. Boesch C, Elsing C, Wegmuller H, Felbinger J, Vock P, Reichen J. Effect of ethanol and fructose on liver metabolism: a dynamic 31 phosphorus magnetic resonance spectroscopy study in normal volunteers. Magn Reson Imaging. 1997;15:1067-1077.
24. Pelleymounter MA, Cullen MF, Baker MB, et al. Effects of the obese gene product on body weight regulation in ob/ob mice. Science. 1995;269:540-543.
25. Iturriaga H, Bunout D, Hirsch S, Ugarte G. Overweight as a risk factor or a predictive sign of histological damage in alcoholics. Am J Clin Nutr. 1988; 47:235-238.
26. Giraud NS, Borotto E, Aubert A, Capron F, Chaput JC. Excess weight' risk factor for alcoholic liver disease. Hepatology. 1997;25:108-111.
27. Hodgson M, Van Thiel DH, Goodman-Klein B. Obesity and hepatotoxin risk factors for fatty liver disease. Br J Ind Med. 1991;48:690-695.
28. Czaja AJ, Carpenter HA, Santrach PJ, Moore SB. Host- and disease-specific factors affecting steatosis in chronic hepatitis C. J Hepatol. 1998;29:198-206.